Cargando…
Potential common mechanism of four Chinese patent medicines recommended by diagnosis and treatment protocol for COVID-19 in medical observation period
The global epidemic has been controlled to some extent, while sporadic outbreaks still occur in some places. It is essential to summarize the successful experience and promote the development of new drugs. This study aimed to explore the common mechanism of action of the four Chinese patent medicine...
Autores principales: | Wang, Lin, Wang, Zheyi, Yang, Zhihua, Wang, Xingwang, Yan, Liping, Wu, Jianxiong, Liu, Yue, Fu, Baohui, Yang, Hongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643314/ https://www.ncbi.nlm.nih.gov/pubmed/36388945 http://dx.doi.org/10.3389/fmed.2022.874611 |
Ejemplares similares
-
Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms
por: Yang, Zhihua, et al.
Publicado: (2023) -
Effect and safety of Chinese patent medicine capsules for recurrent angina pectoris after percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Sun, Yize, et al.
Publicado: (2020) -
Challenges and patenting strategies for Chinese herbal medicine
por: Wang, Xinsheng, et al.
Publicado: (2010) -
Chinese patent medicines for the treatment of the common cold: a systematic review of randomized clinical trials
por: Chen, Wei, et al.
Publicado: (2014) -
Observations on the Use of Patent Medicines
Publicado: (1818)